Lee WA - Search Results

1

Bioavailability improvement of mycophenolic acid through amino ester derivatization.

Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH. Lee WA, et al. Pharm Res. 1990 Feb;7(2):161-6. doi: 10.1023/a:1015828802490. Pharm Res. 1990. PMID: 2308896

2

Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys.

Cundy KC, Fishback JA, Shaw JP, Lee ML, Soike KF, Visor GC, Lee WA. Cundy KC, et al. Among authors: lee wa, lee ml. Pharm Res. 1994 Jun;11(6):839-43. doi: 10.1023/a:1018925723889. Pharm Res. 1994. PMID: 7937523

3

Aryl ester prodrugs of cyclic HPMPC. I: Physicochemical characterization and in vitro biological stability.

Oliyai R, Shaw JP, Sueoka-Lennen CM, Cundy KC, Arimilli MN, Jones RJ, Lee WA. Oliyai R, et al. Among authors: lee wa. Pharm Res. 1999 Nov;16(11):1687-93. doi: 10.1023/a:1018945713623. Pharm Res. 1999. PMID: 10571273

4

Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.

Shaw JP, Sueoko CM, Oliyai R, Lee WA, Arimilli MN, Kim CU, Cundy KC. Shaw JP, et al. Among authors: lee wa. Pharm Res. 1997 Dec;14(12):1824-9. doi: 10.1023/a:1012108719462. Pharm Res. 1997. PMID: 9453075

5

The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.

Lee WA, Ennis RD, Longenecker JP, Bengtsson P. Lee WA, et al. Pharm Res. 1994 May;11(5):747-50. doi: 10.1023/a:1018992716621. Pharm Res. 1994. PMID: 8058647

6

A novel oligodeoxynucleotide inhibitor of thrombin. II. Pharmacokinetics in the cynomolgus monkey.

Lee WA, Fishback JA, Shaw JP, Bock LC, Griffin LC, Cundy KC. Lee WA, et al. Pharm Res. 1995 Dec;12(12):1943-7. doi: 10.1023/a:1016295907266. Pharm Res. 1995. PMID: 8786970

7

Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.

Cundy KC, Sue IL, Visor GC, Marshburn J, Nakamura C, Lee WA, Shaw JP. Cundy KC, et al. Among authors: lee wa. J Pharm Sci. 1997 Dec;86(12):1334-8. doi: 10.1021/js970264s. J Pharm Sci. 1997. PMID: 9423141

8

A novel oligodeoxynucleotide inhibitor of thrombin. I. In vitro metabolic stability in plasma and serum.

Shaw JP, Fishback JA, Cundy KC, Lee WA. Shaw JP, et al. Among authors: lee wa. Pharm Res. 1995 Dec;12(12):1937-42. doi: 10.1023/a:1016243923195. Pharm Res. 1995. PMID: 8786969

9

Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio.

Lee WA, Narog BA, Patapoff TW, Wang YJ. Lee WA, et al. J Pharm Sci. 1991 Aug;80(8):725-9. doi: 10.1002/jps.2600800803. J Pharm Sci. 1991. PMID: 1791529

10

Optimization of in vitro flux through hairless mouse skin of cidofovir, a potent nucleotide analog.

Aspe E, Guy RH, Lee WA, Kennedy JA, Visor GC, Ennis RD. Aspe E, et al. Among authors: lee wa. J Pharm Sci. 1995 Jun;84(6):750-4. doi: 10.1002/jps.2600840617. J Pharm Sci. 1995. PMID: 7562417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters